Medical Journal Articles
An Adaptive Behavioral Intervention for Weight Loss Management: A Randomized Clinical Trial by Bonnie Spring, PhD, Angela F. Pfammatter, PhD , and Laura Scanlan, BA; et al. JAMA May 14, 2024
Financial Incentives for Weight Loss in Men with Obesity by JN Learning JAMA May 14, 2024
Hepatitis C in Black Individuals in the USA Review by Oluwaseun Falade-Nwulia, MBBS, MPH. Sharon M. Kelly, PhD, Sasraku Amanor-Boadu, MD, MPH; et al JAMA November 9, 2o23
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss by Sodhi, MSc, Ramin Rezaeianzadeh, BSc, Abbas Kezouh, PhD, et al JAMA October 4, 2023
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss by Mohit Sodhi, MSc, Ramin Rezaeianzadeh, BSc, Abbas Kezouh, PhD, et al. JAMA October 5. 2023
New Weight Loss Drugs Make Headlines at Diabetes Meeting by Jennifer Abbasi JAMA July 12, 2023
Fasting No Better Than Calorie Counting for Weight Loss by Emily Harris JAMA July 5, 2023
Triple-Hormone Combination Retatrutide Induces 24% Body Weight Loss by Emily Harris JAMA July 5, 2023
Weight Loss Does Not Improve Impaired Brain Responses in People With Obesity by Emily Harris JAMA June 28, 2023
WHO Warns Against Artificial Sugars for Weight Loss by Emily Harris JAMA May 21, 2023
Oral Semaglutide Led to Similar Weight Loss as Injection, Company Says by Emily Harris JAMA May 31, 2023
Sugar Substitutes Don’t Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns by Melissa Suran, PhD, MSJ JAMA June 14, 2023
General Articles and Commentaries
General Reports New Analysis Shows Weight Loss Saves Employers and Medical Costs by Partnership to Fight Chronic Disease
FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name, Zepbound by Meg Tirrell CNN
They took blockbuster drugs for weight loss and diabetes. Now their stomachs are paralyzed by Brenda Goodman CNN